|

Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

RECRUITINGN/ASponsored by Next Biomedical Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorNext Biomedical Co., Ltd.
Started2025-04-17
Est. completion2027-02
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06930677

Summary

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* Osteoarthritis proven by MR-imaging

Exclusion Criteria:

* Current local infection
* Life expectancy less than 6 months

Conditions2

ArthritisKnee Osteoarthritis (Knee OA)

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.